RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

Search

Janus Henderson Group PLC

Uždarymo kaina

47.56 0.02

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

47.54

Max

47.59

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-3.4M

181M

Pardavimai

67M

700M

P/E

Sektoriaus vid.

14.062

25.743

Dividendų pajamingumas

3.34

Pelno marža

25.842

Darbuotojai

2,308

EBITDA

-65M

181M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+6.51% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.34%

3.67%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

134M

7.4B

Ankstesnė atidarymo kaina

47.54

Ankstesnė uždarymo kaina

47.56

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Janus Henderson Group PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-31 22:20; UTC

Pagrindinės rinkos jėgos

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

2025-12-31 17:31; UTC

Pagrindinės rinkos jėgos

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

2025-12-31 16:30; UTC

Pagrindinės rinkos jėgos

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

2025-12-31 15:19; UTC

Pagrindinės rinkos jėgos

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

2025-12-31 15:17; UTC

Pagrindinės rinkos jėgos

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

2025-12-31 14:37; UTC

Pagrindinės rinkos jėgos

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

2026-01-01 23:35; UTC

Rinkos pokalbiai

Gold Rises Amid Geopolitical Risks -- Market Talk

2026-01-01 21:29; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13

2026-01-01 21:29; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Sold Stake in JV to Tata Steel

2026-01-01 21:28; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31

2026-01-01 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-01 09:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-31 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-31 21:13; UTC

Įsigijimai, susijungimai, perėmimai

10 People to Watch in Wealth Management in 2026 -- Barrons.com

2025-12-31 20:40; UTC

Rinkos pokalbiai

Dollar Posting Its Worst Year Since 2017 -- Market Talk

2025-12-31 20:22; UTC

Rinkos pokalbiai

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

2025-12-31 19:50; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

2025-12-31 19:31; UTC

Rinkos pokalbiai

Precious Metals Cap Off Record Runs -- Market Talk

2025-12-31 18:50; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-12-31 18:50; UTC

Rinkos pokalbiai

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

2025-12-31 17:17; UTC

Rinkos pokalbiai

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

2025-12-31 17:16; UTC

Pagrindinės rinkos jėgos

OwlTing Climbs on Launch of $10M Stock-Buyback Program

2025-12-31 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-12-31 17:00; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

2025-12-31 15:57; UTC

Įsigijimai, susijungimai, perėmimai

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

2025-12-31 15:54; UTC

Rinkos pokalbiai

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

2025-12-31 15:02; UTC

Pagrindinės rinkos jėgos

Nike Shares Rise After CEO Hill Buys $1M of Shares

2025-12-31 14:40; UTC

Įsigijimai, susijungimai, perėmimai

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

2025-12-31 14:20; UTC

Rinkos pokalbiai

Crude Futures On Track to End the Year With Losses -- Market Talk

2025-12-31 13:46; UTC

Rinkos pokalbiai

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

Akcijų palyginimas

Kainos pokytis

Janus Henderson Group PLC Prognozė

Kainos tikslas

By TipRanks

6.51% į viršų

12 mėnesių prognozė

Vidutinis 50.71 USD  6.51%

Aukščiausias 55 USD

Žemiausias 48 USD

Remiantis 7 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Janus Henderson Group PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

7 ratings

3

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

33.16 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Neutral Evidence

Ilgalaikis periodas

Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Janus Henderson Group PLC

Janus Henderson Group plc is an asset management holding entity. Through its subsidiaries, the firm provides services to institutional, retail clients, and high net worth clients. It manages separate client-focused equity and fixed income portfolios. The firm also manages equity, fixed income, and balanced mutual funds for its clients. It invests in public equity and fixed income markets, as well as invests in real estate and private equity. Janus Henderson Group plc was founded in 1934 and is based in London, United Kingdom with additional offices in Jersey, United Kingdom and Sydney, Australia.
help-icon Live chat